|
N'-(4-bromophenyl)-N-(4-cyanophenyl)propanediamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N'-(4-chlorophenyl)-N-(4-cyanophenyl)propanediamide |
Depiction based on curated SMILES
O
Cl
N
H
N
O
NH
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N,N'-bis(4-cyanophenyl)-2-methylpropanediamide |
Depiction based on curated SMILES
N
N
H
O
CH
3
N
NH
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N,N'-bis(4-cyanophenyl)propanediamide |
Depiction based on curated SMILES
O
N
NH
N
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(2,4-dimethoxyphenyl)-2-[(5-nitro-1H-benzimidazol-2-yl)thio]acetamide |
Depiction based on curated SMILES
CH
3
O
N
H
_
O
O
+
N
H
3
C
N
S
O
HN
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-(4-cyanophenyl)-N'-(4-phenoxyphenyl)propanediamide |
Depiction based on curated SMILES
O
N
N
H
O
O
NH
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(4-cyanophenyl)-N'-(6-cyanopyridin-3-yl)propanediamide |
Depiction based on curated SMILES
O
N
N
NH
N
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-(4-cyanophenyl)-N'-[4-(trifluoromethyl)phenyl]propanediamide |
Depiction based on curated SMILES
NH
F
F
F
N
O
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Singh VK, et al. 2022. Nat Commun |
|
N-phenyl-2-{[4-(thiophen-2-yl)pyrimidin-2-yl]sulfanyl}acetamide |
Depiction based on curated SMILES
NH
N
S
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3,5-difluorobenzamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
F
F
O
H
2
N
N
H
N
|
Escherichia Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett
|
|
| | |